International Immunology, Vol. 11, No. 2, 151-158,
February 1999
© 1999 Japanese Society for Immunology
Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose
1 Departments of Molecular Genetics,
2 Orthopedics and
3 Anatomy I,Nagoya City University Medical School, 1 Kawasumi, Mizuho-cho, Mizuho-ku,Nagoya 467-8601, Japan
Correspondence to: T. Okamoto
Gold compounds have long been used in the treatment of rheumatoid arthritis (RA). However, their actions in RA have not been clarified. In this study, we examined the effect of one of the monovalent gold compounds, aurothioglucose (AuTG), on the IL-1-induced production of IL-6, IL-8 and granulocyte macrophage colony stimulating factor (GM-CSF) from rheumatoid synovial fibroblasts (RSF) isolated from three RA patients. IL-6 and IL-8 induction but not GM-CSF induction was inhibited in most of the RSF after pretreatment with AuTG. Since gene expression of these cytokines is known to be under the control of a common transcription factor, NF-
B, the effect of AuTG on the cellular localization of NF-B (p65 subunit) and on NF-B–DNA binding was examined. Although AuTG treatment did not prevent NF-B nuclear translocation, AuTG blocked the DNA-binding activity of NF-B when examined in vitro. Morphologically, both metal-specific cell staining using p-dimethylaminobenzylidene rhodamine and transmission electron microscopic examinations demonstrated the accumulation of metal gold in the cytoplama and some organella (mitochondria and lysosomes) of the AuTG-treated RSF. These results indicate that one of the anti-rheumatic actions of AuTG might be through its inhibitory action on NF-B.
Keywords: electron microscopy, NF-B, redox regulation
Transmitting editor: K. Okumura
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Asamitsu, T. Yamaguchi, K. Nakata, Y. Hibi, A.-F. B. Victoriano, K. Imai, K. Onozaki, Y. Kitade, and T. Okamoto Inhibition of Human Immunodeficiency Virus Type 1 Replication by Blocking I{kappa}B Kinase with Noraristeromycin J. Biochem., November 1, 2008; 144(5): 581 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Nishiya, H Wang, K Tahara, and K Hashimoto Enhancement by iron of interleukin 1 induced granulocyte macrophage colony stimulating factor (GM-CSF) production by human synovial fibroblasts Ann Rheum Dis, January 1, 2003; 62(1): 89 - 90. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Georganas, H. Liu, H. Perlman, A. Hoffmann, B. Thimmapaya, and R. M. Pope Regulation of IL-6 and IL-8 Expression in Rheumatoid Arthritis Synovial Fibroblasts: the Dominant Role for NF-{kappa}B But Not C/EBP{beta} or c-Jun J. Immunol., December 15, 2000; 165(12): 7199 - 7206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yoshida, T. Katoh, T. Tetsuka, K. Uno, N. Matsui, and T. Okamoto Involvement of Thioredoxin in Rheumatoid Arthritis: Its Costimulatory Roles in the TNF-{alpha}-Induced Production of IL-6 and IL-8 from Cultured Synovial Fibroblasts J. Immunol., July 1, 1999; 163(1): 351 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Traber, H. Okamoto, C. Kurono, M. Baba, C. Saliou, T. Soji, L. Packer, and T. Okamoto Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-{alpha}-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells Int. Immunol., February 1, 1999; 11(2): 143 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kataoka, H. Handa, and M. Nishizawa Induction of Cellular Antioxidative Stress Genes through Heterodimeric Transcription Factor Nrf2/Small Maf by Antirheumatic Gold(I) Compounds J. Biol. Chem., August 31, 2001; 276(36): 34074 - 34081. [Abstract] [Full Text] [PDF]
|
|